Newsfile Corp
12 Jul 2026, 12:20 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Phreesia announced significantly reduced revenue growth projections for fiscal year 2027 due to worsening visibility and weaker pharmaceutical marketing commitments. — A sharp downward revision in future revenue guidance is a primary driver of fundamental valuation drops and signals deteriorating business health.
-0.80A federal securities class action lawsuit has been filed against Phreesia alleging the company made false or misleading statements regarding its growth potential and revenue streams. — Class action lawsuits introduce significant legal liability, potential settlement costs, and reputational damage that can weigh on the stock price.
-0.50Phreesia's common stock price fell approximately 27% (from $11.41 to $8.38) immediately following the March 30, 2026, announcement. — While this reflects a past move, it confirms the market's negative reaction to the company's fundamental deterioration.
-0.30Continue reading
6 related stories
Search tags
Which stocks this story touches
The company is facing a federal securities class action lawsuit following a 27% stock price drop and allegations of misleading investors regarding revenue growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
2h ago
